MLchartDataset catalogue

flu matrix peptide p58-66

Term · Oncology and biomedicine · MLC-T-ONC-013639

A short chain synthetic antigenic peptide (GILGFVFTL) derived from the influenza virus A matrix protein and presented by HLA-A2 major histocompatibility complex (MHC) class I molecules. Flu matrix peptide p58-66 stimulates the lytic functions of cytotoxic T lymphocytes (CTLs), which may result in the eradication of virus-infected or malignant tumor cells.

Table 1. Record
IdentifierMLC-T-ONC-013639
FieldOncology and biomedicine
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-013639",
  "term": "flu matrix peptide p58-66",
  "field": "Oncology and biomedicine",
  "definition": "A short chain synthetic antigenic peptide (GILGFVFTL) derived from the influenza virus A matrix protein and presented by HLA-A2 major histocompatibility complex (MHC) class I molecules. Flu matrix peptide p58-66 stimulates the lytic functions of cytotoxic T lymphocytes (CTLs), which may result in the eradication of virus-infected or malignant tumor cells.",
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/flu-matrix-peptide-p58-66/"
}

Record 7,375 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.